Back

Full professor K.P.M. (Karijn) Suijkerbuijk

Full professor K.P.M. (Karijn) Suijkerbuijk

Full Professor

Show full profile

Research Output (132)

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Rohaan Maartje W et al. 8 Dec 2022, In: The New England journal of medicine. 387 , p. 2113-2125 13 p.

Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma:A Nation-Wide Study of the Dutch Melanoma Treatment Registry

Rauwerdink Daan Jan Willem, van Doorn Remco, van der Hage Jos, Van den Eertwegh Alfonsus J M, Haanen John B A G, Aarts Maureen, Berkmortel Franchette, Blank Christian U, Boers-Sonderen Marye J, De Groot Jan Willem B, Hospers Geke A P, de Meza Melissa, Piersma Djura, Van Rijn Rozemarijn S, Stevense Marion, Van der Veldt Astrid, Vreugdenhil Gerard, Wouters Michel W J M, Suijkerbuijk Karijn, van der Kooij Monique, Kapiteijn Ellen 19 Nov 2022, In: Cancers. 14

ASO Visual Abstract:Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

Blankenstein Stephanie A, Bonenkamp Johannes J, Aarts Maureen J B, van den Berkmortel Franchette W P J, Blank Christian U, Blokx Willeke A M, Boers-Sonderen Marye J, van den Eertwegh Alfons J M, Franken Margreet G, de Groot Jan Willem B, Haanen John B A G, Hospers Geke A P, Kapiteijn Ellen W, van Not Olivier J, Piersma Djura, van Rijn Rozemarijn S, Suijkerbuijk Karijn P M, van der Veldt Astrid A M, Vreugdenhil Gerard, Westgeest Hans M, Wouters Michel W J M, van Akkooi Alexander C J 1 Nov 2022, In: Annals of Surgical Oncology. 30 , p. 587-588 2 p.

Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

van Not Olivier J, Verheijden Rik J, van den Eertwegh Alfonsus J M, Haanen John B A G, Aarts Maureen J B, van den Berkmortel Franchette W P J, Blank Christian U, Boers-Sonderen Marye J, de Groot Jan-Willem B, Hospers Geke A P, Kamphuis Anna M, Kapiteijn Ellen, May Anne M, de Meza Melissa M, Piersma Djura, van Rijn Rozemarijn, Stevense-den Boer Marion A, van der Veldt Astrid A M, Vreugdenhil Gerard, Blokx Willeke A M, Wouters Michel J M, Suijkerbuijk Karijn P M 27 Oct 2022, In: JAMA Oncology. 8 , p. 1794-1801 8 p.

Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

Blankenstein Stephanie A, Bonenkamp Johannes J, Aarts Maureen J B, van den Berkmortel Franchette W P J, Blank Christian U, Blokx Willeke A M, Boers-Sonderen Marye J, van den Eertwegh Alfons J M, Franken Margreet G, de Groot Jan Willem B, Haanen John B A G, Hospers Geke A P, Kapiteijn Ellen W, van Not Olivier J, Piersma Djura, van Rijn Rozemarijn S, Suijkerbuijk Karijn P M, van der Veldt Astrid A M, Vreugdenhil Gerard, Westgeest Hans M, Wouters Michel W J M, van Akkooi Alexander C J 6 Oct 2022, In: Annals of Surgical Oncology. 30 , p. 573-586 14 p.

Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint Inhibitors

Damen Pim J J, Suijkerbuijk Karijn P M, VAN Lindert Anne S R, Eppinga Wietse S C, El Sharouni Sherif Y, Verhoeff Joost J C Oct 2022, In: Anticancer Research. 42 , p. 4795-4804 10 p.

Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review

Ter Maat Laurens S, van Duin Isabella A J, Elias Sjoerd G, van Diest Paul J, Pluim Josien P W, Verhoeff Joost J C, de Jong Pim A, Leiner Tim, Veta Mitko, Suijkerbuijk Karijn P M 9 Sep 2022, In: European Journal of Cancer. 175 , p. 60-76 17 p.

BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma

van Not Olivier J, Blokx Willeke A M, van den Eertwegh Alfons J M, de Meza Melissa M, Haanen John B, Blank Christian U, Aarts Maureen J B, van den Berkmortel Franchette W P J, de Groot Jan Willem B, Hospers Geke A P, Kapiteijn Ellen, Piersma Djura, van Rijn Rozemarijn S, Stevense-den Boer Marion, van der Veldt Astrid A M, Boers-Sonderen Marye J, Jansen Anne M L, Wouters Michel W J M, Suijkerbuijk Karijn P M Sep 2022, In: JCO Precision Oncology. 6

Metachronous malignancies after response to checkpoint inhibition

de Visser Mirjam A., Verschaeve Francois B., Devriese Lot A., Neyns Bart, Suijkerbuijk Karijn P.M. 17 Aug 2022, In: European Journal of Cancer. 174 , p. 99-101 3 p.

End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma:A Nationwide Cohort Study

van Breeschoten Jesper, Ismail Rawa K, Wouters Michel W J M, Hilarius Doranne L, de Wreede Liesbeth C, Haanen John B, Blank Christian U, Aarts Maureen J B, van den Berkmortel Franchette W P J, de Groot Jan Willem B, Hospers Geke A P, Kapiteijn Ellen, Piersma Djura, van Rijn Rozemarijn S, Stevense-den Boer Marion A, van der Veldt Astrid A M, Vreugdenhil Gerard, Boers-Sonderen Marye J, Suijkerbuijk Karijn P M, UMC Amsterdam 9 Aug 2022, In: JCO oncology practice. 18 , p. e1611-e1620

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not